.@AnthropicAI rings the opening bell to mark its initial public offering at Nasdaq. $ANT
77
every $HIMS bullish should unfollow HimsHouse
it is clear -> them are supporting other companies
fore me Care+ is a must, if you want peptides
$HIMS is not a joke
10
586
here we gooooo $HIMS
More than 10,000 people signed up for early access when we launched the waitlist two weeks ago for Peptides+. Starting today, they all have access to a comprehensive intake that will be the beginning of a journey with a provider to find whether a personalized treatment plan is right for them.
Clinically-guided protocols. At-home blood collection. The full support of a care team that knows you, your progress, and your goals. And 5 US-compounded treatments, with more to come soon.
Itโs exactly what we think health should be: easy, personal, high-quality, supported by independent experts, and on the cutting edge of where science is going.
We canโt wait to see where those journeys take you.
Read more here, including important info: investors.hims.com/news/newsโฆ
3
90
here we gooo $HIMS
Peptides+ is officially here. Five U.S.-compounded treatments, backed by personalized, clinically-guided care from independent, licensed providers. Read more: investors.hims.com/news/newsโฆ
6
385
... $HIMS
6
399
Simon the Italian ๐ฎ๐น retweeted
๐จ $HIMS vs $Ro might be the dumbest comparison on X right now.
Ro is privately held, selectively sharing its best numbers while potentially positioning itself for an IPO.
Meanwhile, $HIMS is publicly traded, exposing its financials, losses, margins, and challenges every quarter.
Youโre comparing Roโs highlights to Himsโ entire financial report. ๐คก
And letโs not pretend theyโre playing the same game.
$HIMs is building a much bigger, increasingly global healthcare platform through acquisitions, international expansion, and a growing product ecosystem.
Ro is a competitor. But comparing the two without complete financial transparency is ridiculous.
Show us Roโs full financials first. Then we can talk.
The moment has come to reclaim what's yours @AndrewDudum
Let's make everyone see what you're actually building here $HIMS
I have infinite trust in you Andrew, bought everything I was able to buy
I am getting so many $HIMS shares as possible.
When I got my first share they were doing $75M per Q, in Q1 2027 they will do $1B
Only pussies are selling here.
1
23
578
buying more $HIMS โฆeveryone has forgotten all the investment this company has done for Peptides and AI
The moment has come to reclaim what's yours @AndrewDudum
Let's make everyone see what you're actually building here $HIMS
Simon the Italian ๐ฎ๐น retweeted
As a pharmacy owner, $HIMS could put me out of business whenever it wants.
Hereโs why Iโm bullish on the stock.
Getting testosterone cypionate through my pharmacy:
Doctorโs consultation: ยฃ300
Blood tests: ยฃ350
Testosterone cypionate (3-month supply): ยฃ233
Total: ยฃ883 (~$1,185) for 3 months
Getting it through $HIMS:
$79/month = $237 for 3 months.
Same treatment. A fraction of the cost.
This is what disrupting healthcare looks like.
$HIMS is getting ready, according to @AndrewDudum
5
353

















